GastroenterologyAn R&D Focus
With years upon years of first-hand experience in advancing the development of the modern medicine and drugs, we know how to make the world healthier!
ReHealth’s development programs in Gastroenterology are focused on advancing new treatments in constipation and diabetic gastroparesis. Key programs include low-dose and colonic release formulations for Linzess and relamorelin, a novel treatment for Diabetic Gastroparesis, a debilitating condition that has not had a new therapeutic option in more than 30 years.
Here's how it works:
ReHealth’s development efforts in anti-infectives are focused on bringing forward treatments for difficult to treat infections.
Lead programs include Ceftazidime/Avibactam, a potential treatment for hospital acquired bacteria pneumonia/ventilator acquired bacterial pneumonia.
Also we focus on Aztreonam/Avibactam, a novel treatment for gram-negative infections. ReHealth is also focused on adding new innovative programs throughout its seven therapeutic areas.
Apply for a Job with Us!
Each year we’ve got a lot of miscellaneous job offerings. See which ones are right for you!